Cabio Biotech (Wuhan) Co., Ltd.

SHSE:688089 Stock Report

Market Cap: CN¥3.6b

Cabio Biotech (Wuhan) Dividends and Buybacks

Dividend criteria checks 2/6

Cabio Biotech (Wuhan) is a dividend paying company with a current yield of 0.92% that is well covered by earnings.

Key information

0.9%

Dividend yield

0.2%

Buyback Yield

Total Shareholder Yield1.2%
Future Dividend Yield0%
Dividend Growth6.9%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareCN¥0.200
Payout ratio29%

Recent dividend and buyback updates

Recent updates

We Think That There Are Issues Underlying Cabio Biotech (Wuhan)'s (SHSE:688089) Earnings

Nov 04
We Think That There Are Issues Underlying Cabio Biotech (Wuhan)'s (SHSE:688089) Earnings

Cabio Biotech (Wuhan) (SHSE:688089) Might Be Having Difficulty Using Its Capital Effectively

Oct 28
Cabio Biotech (Wuhan) (SHSE:688089) Might Be Having Difficulty Using Its Capital Effectively

Subdued Growth No Barrier To Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) With Shares Advancing 31%

Oct 01
Subdued Growth No Barrier To Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) With Shares Advancing 31%

There's Reason For Concern Over Cabio Biotech (Wuhan) Co., Ltd.'s (SHSE:688089) Massive 25% Price Jump

Aug 06
There's Reason For Concern Over Cabio Biotech (Wuhan) Co., Ltd.'s (SHSE:688089) Massive 25% Price Jump

Cabio Biotech (Wuhan) (SHSE:688089) Could Be Struggling To Allocate Capital

Jun 07
Cabio Biotech (Wuhan) (SHSE:688089) Could Be Struggling To Allocate Capital

Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected

May 06
Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected

Cabio Biotech (Wuhan)'s (SHSE:688089) Promising Earnings May Rest On Soft Foundations

May 03
Cabio Biotech (Wuhan)'s (SHSE:688089) Promising Earnings May Rest On Soft Foundations

The Market Lifts Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Shares 27% But It Can Do More

Mar 21
The Market Lifts Cabio Biotech (Wuhan) Co., Ltd. (SHSE:688089) Shares 27% But It Can Do More

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 688089 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 688089 has only been paying a dividend for 4 years, and since then payments have fallen.


Dividend Yield vs Market

Cabio Biotech (Wuhan) Dividend Yield vs Market
How does 688089 dividend yield compare to the market?
SegmentDividend Yield
Company (688089)0.9%
Market Bottom 25% (CN)0.6%
Market Top 25% (CN)2.2%
Industry Average (Chemicals)1.8%
Analyst forecast (688089) (up to 3 years)0%

Notable Dividend: 688089's dividend (0.92%) is higher than the bottom 25% of dividend payers in the CN market (0.55%).

High Dividend: 688089's dividend (0.92%) is low compared to the top 25% of dividend payers in the CN market (2.16%).


Earnings Payout to Shareholders

Earnings Coverage: With its reasonably low payout ratio (29.5%), 688089's dividend payments are well covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: 688089 is paying a dividend but the company has no free cash flows.


Discover strong dividend paying companies